Started as a clinical thermometer producer in Japan in 1921, Terumo is a comprehensive medical device player with a diversified global revenue... Show more
TRUMF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 26 cases where TRUMF's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for TRUMF just turned positive on July 03, 2025. Looking at past instances where TRUMF's MACD turned positive, the stock continued to rise in of 65 cases over the following month. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where TRUMF advanced for three days, in of 233 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 70 cases where TRUMF's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on July 03, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on TRUMF as a result. In of 141 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
TRUMF moved below its 50-day moving average on June 30, 2025 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for TRUMF crossed bearishly below the 50-day moving average on June 17, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 22 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TRUMF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for TRUMF entered a downward trend on July 01, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.130) is normal, around the industry mean (24.348). P/E Ratio (39.216) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.009) settles around the average of (0.018) among similar stocks. P/S Ratio (4.277) is also within normal values, averaging (42.660).
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. TRUMF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TRUMF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
Industry MedicalSpecialties
A.I.dvisor tells us that TRUMF and SKHHY have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TRUMF and SKHHY's prices will move in lockstep.
Ticker / NAME | Correlation To TRUMF | 1D Price Change % | ||
---|---|---|---|---|
TRUMF | 100% | +0.15% | ||
SKHHY - TRUMF | 22% Poorly correlated | -0.21% | ||
ANSLY - TRUMF | 20% Poorly correlated | N/A | ||
SSMXY - TRUMF | 9% Poorly correlated | -0.82% | ||
UEEC - TRUMF | 5% Poorly correlated | -6.81% | ||
VPTDF - TRUMF | 3% Poorly correlated | -6.38% | ||
More |